Back to companies

SAMSUNG PHARMACEUTICAL.CO.,Ltd.

001360KRKRX

삼성제약

Revenue
₩44.3bn
FY2024
Operating income
-₩14.8bn
FY2024
Employees
—
Founded
—

Source: Korea Financial Supervisory Service DART (Open DART API)